✦ LIBER ✦

Mucosal immunization with HIV-1 gag DNA on cationic microparticles prolongs gene expression and enhances local and systemic immunity

✍ Scribed by Manmohan Singh; Michael Vajdy; Jason Gardner; Maylene Briones; Derek O’Hagan

Book ID: 117430611
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 279 KB
Volume: 20
Category: Article
ISSN: 0264-410X
DOI: 10.1016/s0264-410x(01)00321-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clustered epitopes within the Gag–Pol fu

Clustered epitopes within the Gag–Pol fusion protein DNA vaccine enhance immune responses and protection against challenge with recombinant vaccinia viruses expressing HIV-1 Gag and Pol antigens

✍ Elizabeth Bolesta; Jaroslaw Gzyl; Andrzej Wierzbicki; Dariusz Kmieciak; Aleksand 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 545 KB

Potent specific immune responses induced

Potent specific immune responses induced by prime-boost-boost strategies based on DNA, adenovirus, and Sendai virus vectors expressing gag gene of Chinese HIV-1 subtype B

✍ Shuangqing Yu; Xia Feng; Tsugumine Shu; Tetsuro Matano; Mamoru Hasegawa; Xiaoli 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 714 KB

Corrigendum to “Clustered epitopes withi

Corrigendum to “Clustered epitopes within the Gag–Pol fusion protein DNA vaccine enhance immune responses and protection against challenge with recombinant vaccinia viruses expressing HIV-1 Gag and Pol antigens ” [Virology 332 (2005) 467–479]

✍ Elizabeth Bolesta; Jaroslaw Gzyl; Andrzej Wierzbicki; Dariusz Kmieciak; Aleksand 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Parenteral and oral immunization with a

Parenteral and oral immunization with a plasmid DNA expressing the human papillomavirus 16-L1 gene induces systemic and mucosal antibodies and cytotoxic T lymphocyte responses

✍ Leticia Rocha-Zavaleta; Jorge E. Alejandre; Alejandro Garcia-Carranca 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 374 KB

## Abstract The association of human papillomavirus (HPV) infection and cervical cancer has been demonstrated. The development of a prophylactic vaccine to protect against primary HPV infection may therefore be an efficient means to reduce the incidence of this cancer worldwide. To assess the capac